{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.86 vs. cons $1.82",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth",
      "prediction": "IN-LINE",
      "answer": "pred ~3.0% vs. cons 2.5%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Segment margin",
      "prediction": "IN-LINE",
      "answer": "pred ~19.2% vs. cons 19.1%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.10 vs. cons $8.10 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 organic sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~2.5% vs. cons 2.5% (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 segment-margin expansion",
      "prediction": "UNCHANGED",
      "answer": "guide ~245 bps vs. cons 245 bps (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 free cash flow",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.00B vs. cons $2.00B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2H2026 organic sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~4.0% vs. cons 4.0% (2H2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2H2026 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$4.55 vs. cons $4.55 (2H2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "A modest ~$0.04 EPS beat and stable ~3.0% organic growth should initially reward execution, but unchanged FY EPS (~$8.10) and 2H EPS (~$4.55) leave out-period estimates broadly intact; the cash and PA&T conversion burden remains concentrated in 2H.",
  "day5_confidence": "MEDIUM"
}